Medicine and Dentistry
Adverse Event
6%
Antibiotics
6%
Apolipoprotein B mRNA Editing Enzyme Catalytic Polypeptide Like
33%
Autosomal Dominant Inheritance
11%
Autosomal Recessive Inheritance
33%
Blister
22%
Cell Therapy
33%
Clinical Assessment
11%
Clinical Feature
13%
Clinical Management
11%
Cohort Effect
33%
Collagen Type 7
16%
Combination Therapy
6%
Crohn's Disease
33%
Disease Activity Score
6%
Diseases
34%
Drive
33%
Drug Repositioning
33%
Edema
13%
Epidermolysis Bullosa Dystrophica
100%
Epidermolysis Bullosa Simplex
33%
Gene Expression Profiling
6%
Granulomatosis
33%
Gut
6%
Hypopigmentation
11%
Immunomodulation
6%
Infusion
6%
Laboratory Diagnosis
11%
Limb
11%
Mercaptopurine
6%
Mesenchymal Stem Cell
33%
Mosaicism
11%
Neonates
11%
Neoplasm
7%
Nevus Sebaceous
33%
Open-Label Trial
33%
Placebo
6%
Pruritus
6%
Rigosertib
33%
Serositis
6%
Skin Fragility
11%
Spontaneous Remission
6%
Squamous Cell Carcinoma
33%
Stem Cell
20%
Systematic Review
33%
Transcriptomics
33%
Tumor Necrosis
13%
Ulcer
6%
Wound
20%
Wound Healing
40%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
11%
Antibiotics
6%
Clinical Feature
13%
Clinical Trial
11%
Collagen Type 7
14%
Combination Therapy
6%
Complementary DNA
22%
Crohn's Disease
33%
Cytokine
6%
Diseases
17%
Drug Repositioning
33%
Edema
13%
Epidermolysis
33%
Epidermolysis Bullosa Dystrophica
66%
Gastrointestinal Symptom
6%
Granulomatosis
33%
Human Study
11%
Immunomodulation
6%
Inflammation
6%
Inflammatory Bowel Disease
6%
Mercaptopurine
6%
Phase I Trials
11%
Phosphoglycerate Kinase
11%
Prospective Study
6%
Remission
13%
Rigosertib
33%
Skin Fragility
11%
Tumor Necrosis
13%
Ulcer
6%
Wound
20%
Wound Healing
33%
Biochemistry, Genetics and Molecular Biology
Anchoring Fibrils
25%
APOBEC
33%
Autoimmunity
16%
Basement Membrane
8%
Clinical Trial
8%
Codon
16%
Drive
33%
Epidermolysis bullosa
66%
Fibroblast
33%
Gene Therapy
33%
Human Study
8%
Phase I Trials
8%
Phosphoglycerate Kinase
8%
Promoter Region
8%
Transgene
25%
